CENDAKIMAB

UNII: O8R9U9ZUVN
Preferred Substance Name: CENDAKIMAB

2151032-62-9
ABT-308
CC-93538
CENDAKIMAB [INN]
CENDAKIMAB [USAN]
CENDAKIMAB [WHO-DD]
HUMANIZED ANTI-HUMAN IL-13 MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G1(240-ALANINE, 241-ALANINE), ANTI-(HUMAN INTERLEUKIN 13) (HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .GAMMA.-1), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .KAPPA.-1, DIMER
RPC-4046

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

CENDAKIMAB

Synonyms and Mappings

Resources

Note